Study Details

Back to Search Results

Study to evaluate the efficacy, safety, and tolerability of Mirabegron in older adult subjects with overactive bladder (OAB)

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT02216214

Astellas Study ID

The unique identification code given by the study sponsor.

178-MA-1005

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Overactive Bladder Disease

Phase

These clinical trials happen after a drug or treatment has been approved for patients to take. Clinical trials in phase 4 usually take place over many years because researchers want to learn about long term use and safety of a drug or treatment.

Phase 4

Age

65 years - N/A

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Oct 2014 - Jan 2018

Masking

Double (Participant, Investigator)

Enrollment number

888

A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for Study to evaluate the efficacy, safety, and tolerability of Mirabegron in older adult subjects with overactive bladder (OAB)? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Site US00007

North Miami, United States, 33161

Site US00029

Miami, United States, 33144

Site US00098

Tacoma, United States, 98405

Site US00014

Las Vegas, United States, 89148

Site US00082

Moncks Corner, United States, 29461

Site US00148

Mobile, United States, 36608

Site US00115

Los Angeles, United States, 90033

Site CA00168

Toronto, Canada, M4S 1Y2

Site US00157

Wellington, United States, 33449

Site US00133

Cincinnati, United States, 45212

Site US00093

Saginaw, United States, 48604

Site US00064

Brooksville, United States, 34601

Site US00176

Anaheim, United States, 92801

Site US00091

Brockton, United States, 02301

Site US00087

Nashville, United States, 37209

Site US00018

Edgewater, United States, 32132

Site US00144

Santa Maria, United States, 93454

Site US00146

Voorhees, United States, 08042

Site US00101

Buffalo, United States, 14203

Site US00030

Gastonia, United States, 28054

Site US00081

Little Rock, United States, 72205

Site US00154

Chattanooga, United States, 37421

Site US00039

Denver, United States, 80220

Site US00046

Jeffersonville, United States, 47130

Site US00132

Concord, United States, 28025

Site US00027

Fleming Island, United States, 32003

Site US00090

Washington, United States, 20010

Site US00135

San Diego, United States, 92117

Site US00045

Overland Park, United States, 66202

Site CA00164

Lévis, Canada, G6W 0M6

Site CA00126

Hamilton, Canada, L8N 4A6

Site US00021

Pompano Beach, United States, 33060

Site US00048

Beverly Hills, United States, 90211

Site US00134

West Des Moines, United States, 50266

Site US00103

Portland, United States, 97239

Site US00104

Augusta, United States, 67010

Site US00086

Norfolk, United States, 23502

Site US00043

Williamsville, United States, 14221

Site US00174

Hurst, United States, 76054

Site US00137

Sartell, United States, 56377

Site US00015

Middleburg Heights, United States, 44130

Site US00006

New Bedford, United States, 02740

Site US00178

Alpharetta, United States, 30005

Site US00042

Miami, United States, 33173

Site US00016

Brooklyn, United States, 11215

Site US00153

Charlotte, United States, 28209

Site CA00074

Vancouver, Canada, V6J1S3

Site CA00169

Sudbury, Canada, P3E 3Z9

Site US00067

Akron, United States, 44313

Site CA00106

Point Claire, Canada, H9R4S3

Site US00003

Kalamazoo, United States, 49009

Site US00019

Tucson, United States, 85745

Site US00173

Mobile, United States, 36608

Site US00008

Tempe, United States, 85282

Site US00111

New Brunswick, United States, 08901

Site US00034

Los Angeles, United States, 90027

Site US00035

Port Orange, United States, 32129

Site US00069

Dallas, United States, 75390

Site US00053

Franklin, United States, 37064

Site US00079

Oklahoma City, United States, 73104

Site US00084

Mentor, United States, 44094

Site US00044

Salt Lake City, United States, 84107

Site US00024

Edina, United States, 55435

Site US00131

Houston, United States, 77030

Site US00036

Salt Lake City, United States, 84124

Site US00062

Madison, United States, 53715

Site US00108

Nashville, United States, 37232

Site US00083

Stanford, United States, 94305

Site US00076

Lakeland, United States, 33805

Site US00179

Jupiter, United States, 33458

Site US00166

Winston-Salem, United States, 27103

Site US00175

Austin, United States, 78705

Site US00004

Denver, United States, 80239

Site US00066

Huntsville, United States, 35801

Site US00040

New London, United States, 06320

Site CA00118

London, Canada, N6A 4V2

Site US00180

Pittsburgh, United States, 15236

Site US00005

Savannah, United States, 31406

Site US00037

Miami, United States, 33135

Site US00010

Murrieta, United States, 92562

Site CA00073

Point Claire, Canada, H9R4S3

Site CA00130

Edmonton, Canada, T5G 0B7

Site US00088

Indianapolis, United States, 46202

Site US00177

Poughkeepsie, United States, 12601

Site CA00156

Sherbrooke, Canada, J1H 1Z1

Site US00023

West Jordan, United States, 84088

Site US00011

Smyrna, United States, 37167

Site CA00061

Sherbrooke, Canada, J1H5N2

Site US00071

San Antonio, United States, 78229

Site US00050

Cincinnati, United States, 45249

Site US00017

Deland, United States, 32720

Site US00041

Boise, United States, 83642

Site US00145

Watertown, United States, 02472

Site US00052

Nashville, United States, 37211

Site US00099

Tampa, United States, 33606

Site CA00155

Brampton, Canada, L6T 4S5

Site US00109

Orange, United States, 92862

Site US00026

Colorado Springs, United States, 80907

Site US00150

Hawaiian Gardens, United States, 90716

Site CA00116

Sarnia, Canada, N7T4X3

Site US00140

Albuquerque, United States, 87102

Site US00009

Anchorage, United States, 99503

Site US00165

Wilmington, United States, 28401

Site CA00160

Quebec, Canada, G1X 0B6

Site US00122

Greensboro, United States, 27403

Site US00172

Lake Charles, United States, 70601

Site US00142

Beverly Hills, United States, 90212

Site US00075

St. Petersburg, United States, 33709

Site US00002

Debary, United States, 32713

Site US00167

Seattle, United States, 98150

Site US00112

Los Angeles, United States, 90017

Site US00095

Cleveland, United States, 44109

Site US00159

Billings, United States, 59102

Site US00161

Raleigh, United States, 27609

Site US00125

LaCrosse, United States, 54601

Site US00170

Newport News, United States, 23606

Site US00085

Fargo, United States, 58103

Site US00139

San Diego, United States, 92120

Site US00136

Northglenn, United States, 80234

Site US00070

Norfolk, United States, 68701

Site US00105

Newton, United States, 67114

Site CA00129

Quebec, Canada, G1S2L6

Site CA00123

Corunna, Canada, N0N1G0

Site US00001

Deland, United States, 32720

Site US00063

Little Rock, United States, 72120

Site US00068

San Antonio, United States, 78209

Site US00057

Kissimmee, United States, 34744

Site US00151

Hialeah, United States, 33016

Site US00117

Franklin, United States, 37067

Site US00102

Norman, United States, 73069

Site US00060

Greenwood, United States, 46143

Site US00020

Tucson, United States, 85715

Site CA00158

Montreal, Canada, H2Y 1S1

Site US00013

Houston, United States, 77055

Site US00162

Mount Pleasant, United States, 29464

Site US00032

Bristol, United States, 37620

Site US00056

Grand Rapids, United States, 49503

Site US00113

East Brunswick, United States, 08816

Site US00025

Annapolis, United States, 21401

Site US00100

San Antonio, United States, 78229

Site US00080

Coral Gables, United States, 33134

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo